# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-043279
Filing Date
2025-05-14
Accepted
2025-05-14 16:02:15
Documents
78
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0239898-10q_oruka.htm iXBRL | 10-Q | 1118051
2 | PARUKA WARRANT, DATED DECEMBER 31, 2024 | ea023989801ex4-5_oruka.htm | EX-4.5 | 67901
3 | CERTIFICATION | ea023989801ex31-1_oruka.htm | EX-31.1 | 12911
4 | CERTIFICATION | ea023989801ex31-2_oruka.htm | EX-31.2 | 12606
5 | CERTIFICATION | ea023989801ex32-1_oruka.htm | EX-32.1 | 7940
| Complete submission text file | 0001213900-25-043279.txt |  | 6813369

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | orka-20250331.xsd | EX-101.SCH | 66960
7 | XBRL CALCULATION FILE | orka-20250331_cal.xml | EX-101.CAL | 31574
8 | XBRL DEFINITION FILE | orka-20250331_def.xml | EX-101.DEF | 323411
9 | XBRL LABEL FILE | orka-20250331_lab.xml | EX-101.LAB | 545161
10 | XBRL PRESENTATION FILE | orka-20250331_pre.xml | EX-101.PRE | 342839
81 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0239898-10q_oruka_htm.xml | XML | 843390

Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 25945159
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)